+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
Albumin Excipient Market Report 2025 - Product Thumbnail Image

Albumin Excipient Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Leukocyte Adhesion Deficiency Management Market Report 2025 - Product Thumbnail Image

Leukocyte Adhesion Deficiency Management Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
From
From
Licensing Deals in Biotechnology 2020-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2020-2025

  • Report
  • September 2025
  • 1000 Pages
  • Global
From
Collaboration Deals in Biotechnology 2020-2025 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2020-2025

  • Report
  • September 2025
  • 900 Pages
  • Global
From
Plasma Protein Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Plasma Protein Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 186 Pages
  • Global
From
From
From
From
From
Loading Indicator